Skip to content

Genpact G Common Stock Shares Outstanding

Common Stock Shares Outstanding at other companies

Alignment Healthcare logo
Alignment HealthcareALHC
$6.48M-54.4%
STU
StubHub Holdings, Inc.STUB
$9.57M
Genpact logo
GenpactG
$25.3M
Corebridge Financial logo
Corebridge FinancialCRBG
$10.6M+0.8%
UiPath logo
UiPathPATH
$70.63M-34.1%
Astera Labs, Inc. logo
Astera Labs, Inc.ALAB
$285.22M+5.1%

Other financials

Income statement

See full
Revenue$1.3B+6.7%
Gross profit$471.7M+9.9%
Operating income$198.6M+8.1%
Net income$148.0M+13.1%
EPS (diluted)$0.86+17.8%

Balance sheet

See full
Cash & equivalents$578.1M+2.9%
Total debt$1.4B-4.9%
Total equity$2.5B+0.9%
Total assets$5.6B+14.8%

Cash flow

See full
Operating cash flow-$23.5M-158%
CapEx$23.9M+8.9%
Free cash flow-$47.5M-357%

Valuation

See full
Market cap$4.79B-28.5%
Enterprise value$5.58B-26.9%
P/E8.4×-4.3×
P/S0.9×-0.5×

Profitability

See full
Gross margin36.3%+0.8pp
Operating margin14.8%-0.1pp
Net margin11%+0.2pp
FCF margin13%+0.6pp

Returns & leverage

See full
Return on equity23.1%+0.9pp
Debt / equity0.6×0.0×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Genpact in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.

The official record: Genpact’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Genpact's common stock shares outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Genpact's common stock shares outstanding?
Genpact (G) reported common stock shares outstanding of $25.3M in Q1 2026.
What does common stock shares outstanding mean?
This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.